113 related articles for article (PubMed ID: 23719280)
1. Design, synthesis and biological activity evaluation of desloratadine analogues as H1 receptor antagonists.
Lin Y; Wang Y; Sima LF; Wang DH; Cao XH; Chen LG; Chen B
Bioorg Med Chem; 2013 Jul; 21(14):4178-85. PubMed ID: 23719280
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antihistamine evaluations of several N-hydroxyalkyl desloratadine analogues.
Lin Y; Wang Y; Sima LF; Wang DH; Chen LG; Li L
Med Chem; 2012 Nov; 8(6):1126-32. PubMed ID: 22779794
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective synthesis of desloratadine derivatives as antagonist of histamine.
Liu GZ; Xu HW; Chen GW; Wang P; Wang YN; Liu HM; Yu DQ
Bioorg Med Chem; 2010 Feb; 18(4):1626-32. PubMed ID: 20110173
[TBL] [Abstract][Full Text] [Related]
4. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antihistamine evaluations of novel loratadine analogues.
Wang Y; Wang J; Lin Y; Si-Ma LF; Wang DH; Chen LG; Liu DK
Bioorg Med Chem Lett; 2011 Aug; 21(15):4454-6. PubMed ID: 21733682
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel desloratadine derivatives with anti-inflammatory and H
Li F; Xu Q; Zhu Q; Chu Z; Lin G; Mo J; Zhao Y; Li J; He G; Xu Y
Bioorg Med Chem Lett; 2019 Dec; 29(24):126712. PubMed ID: 31679973
[TBL] [Abstract][Full Text] [Related]
8. Anti-allergic and anti-inflammatory properties of a potent histamine H1 receptor antagonist, desloratadine citrate disodium injection, and its anti-inflammatory mechanism on EA.hy926 endothelial cells.
Jie Q; Kodithuwakku ND; Yuan X; He G; Chen M; Xu S; Wu Y
Eur J Pharmacol; 2015 May; 754():1-10. PubMed ID: 25704613
[TBL] [Abstract][Full Text] [Related]
9. Route to Prolonged Residence Time at the Histamine H
Bosma R; Wang Z; Kooistra AJ; Bushby N; Kuhne S; van den Bor J; Waring MJ; de Graaf C; de Esch IJ; Vischer HF; Sheppard RJ; Wijtmans M; Leurs R
J Med Chem; 2019 Jul; 62(14):6630-6644. PubMed ID: 31274307
[TBL] [Abstract][Full Text] [Related]
10. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects.
Kreutner W; Hey JA; Chiu P; Barnett A
Arzneimittelforschung; 2000 May; 50(5):441-8. PubMed ID: 10858871
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and pharmacological screening of a series of N1-(substituted) aryl-5,7-dimethyl-2-(substituted)pyrido(2,3-d)-pyrimidin-4(3H)-ones as potential histamine H1-receptor antagonists.
Suhagia BN; Chhabria MT; Makwana AG
J Enzyme Inhib Med Chem; 2006 Dec; 21(6):681-91. PubMed ID: 17252940
[TBL] [Abstract][Full Text] [Related]
12. Effect of desloratadine and loratadine on rhinovirus-induced intercellular adhesion molecule 1 upregulation and promoter activation in respiratory epithelial cells.
Papi A; Papadopoulos NG; Stanciu LA; Degitz K; Holgate ST; Johnston SL
J Allergy Clin Immunol; 2001 Aug; 108(2):221-8. PubMed ID: 11496238
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and histamine H1-receptor antagonistic activity of some novel 4-amino-2-(substituted)-5-(substituted) aryl-6-[(substituted aryl) amino] pyrimidines.
Chhabria MT; Patel VT; Rajan KS; Brahmkshatriya PS
Arzneimittelforschung; 2009; 59(5):243-7. PubMed ID: 19537525
[TBL] [Abstract][Full Text] [Related]
14. Form I of desloratadine, a tricyclic antihistamine.
Bhatt PM; Desiraju GR
Acta Crystallogr C; 2006 Jun; 62(Pt 6):o362-3. PubMed ID: 16763328
[TBL] [Abstract][Full Text] [Related]
15. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models.
Orzechowski RF; Currie DS; Valancius CA
Eur J Pharmacol; 2005 Jan; 506(3):257-64. PubMed ID: 15627436
[TBL] [Abstract][Full Text] [Related]
16. Anticholinergic effects of desloratadine, the major metabolite of loratadine, in rabbit and guinea-pig iris smooth muscle.
Cardelús I; Antón F; Beleta J; Palacios JM
Eur J Pharmacol; 1999 Jun; 374(2):249-54. PubMed ID: 10422766
[TBL] [Abstract][Full Text] [Related]
17. In vivo antimuscarinic actions of the third generation antihistaminergic agent, desloratadine.
Howell G; West L; Jenkins C; Lineberry B; Yokum D; Rockhold R
BMC Pharmacol; 2005 Aug; 5():13. PubMed ID: 16109168
[TBL] [Abstract][Full Text] [Related]
18. Impact of desloratadine and loratadine on the crosstalk between human keratinocytes and leukocytes: Implications for anti-inflammatory activity of antihistamines.
Traidl-Hoffmann C; Münster I; Ring J; Behrendt H
Int Arch Allergy Immunol; 2006; 140(4):315-20. PubMed ID: 16741367
[TBL] [Abstract][Full Text] [Related]
19. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
[TBL] [Abstract][Full Text] [Related]
20. Hybrid approach for the design of highly affine and selective dopamine D(3) receptor ligands using privileged scaffolds of biogenic amine GPCR ligands.
Sasse BC; Mach UR; Leppaenen J; Calmels T; Stark H
Bioorg Med Chem; 2007 Dec; 15(23):7258-73. PubMed ID: 17826096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
